NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 67 filers reported holding NOVELION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,000 | -50.0% | 1,296 | -50.3% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 2,606 | +79.5% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 1,452 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -80.0% | 1,452 | -12.8% | 0.00% | – |
Q3 2018 | $5,000 | -89.1% | 1,665 | -86.7% | 0.00% | – |
Q2 2018 | $46,000 | +475.0% | 12,522 | +458.0% | 0.00% | – |
Q1 2018 | $8,000 | -20.0% | 2,244 | -31.2% | 0.00% | – |
Q4 2017 | $10,000 | -80.8% | 3,263 | -55.9% | 0.00% | – |
Q3 2017 | $52,000 | -21.2% | 7,402 | +4.3% | 0.00% | – |
Q2 2017 | $66,000 | -24.1% | 7,097 | -11.8% | 0.00% | – |
Q1 2017 | $87,000 | +17.6% | 8,047 | -8.0% | 0.00% | – |
Q4 2016 | $74,000 | – | 8,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|